Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in Epidemiol Infect Retrieve available abstracts of 148 articles: HTML format

Single Articles

September 2025
1. VAN DER ROEST B, Fischer EAJ, Klinkenberg D, Bootsma MCJ, et al
   Phylodynamic inference suggests introductions as main driver of Mpox Clade II outbreak in 2022 in Slovenia.
   Epidemiol Infect. 2025;153:e115.
   PubMed     Abstract available
   
   
   
2. WOLDEGIORGIS M, Bloomfield L, Korda R, Cadby G, et al
   Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.
   Epidemiol Infect. 2025;153:e116.
   PubMed     Abstract available
   
   
   August 2025
3. PARRADO R, Cuba-Grandy CX, Fuentes-Luppichini E, Torrico Villarroel NG, et al
   Multiplex RT-qPCR strategy for SARS-CoV-2 variants detection in developing countries without ngs: The Bolivian experience.
   Epidemiol Infect. 2025;153:e94.
   PubMed     Abstract available
   
   
   
4. BUBAR K, Middleton C, Larremore D, Gostic K, et al
   A fundamental limit to the effectiveness of traveller screening with molecular tests.
   Epidemiol Infect. 2025;153:e95.
   PubMed     Abstract available
   
   
   
5. CHOI H, Hwang M, Coppin JD, Chatterjee P, et al
   Penetration of SARS-CoV-2 Alpha, Delta, and Omicron variants in the United States.
   Epidemiol Infect. 2025;153:e92.
   PubMed     Abstract available
   
   
   July 2025
6. WU S, Feng Y, Cheng H, Huang H, et al
   Personalized risk score prediction and testing policy adaptations of a COVID-19 population-based contact tracing network.
   Epidemiol Infect. 2025;153:e90.
   PubMed     Abstract available
   
   
   
7. DO DA, Duy-Nguyen VM, Nguyen TH, Le DT, et al
   Antibiotic resistance among ICU patients during the COVID-19 pandemic and its associated factors: a retrospective study using electronic medical records in two Vietnamese hospitals.
   Epidemiol Infect. 2025;153:e93.
   PubMed     Abstract available
   
   
   
8. KELLY GE, Petti S, Noah N
   Excess respiratory, circulatory, neoplasm, and other mortality rates during the Covid-19 pandemic in the EU and their implications.
   Epidemiol Infect. 2025;153:e86.
   PubMed     Abstract available
   
   
   June 2025
9. SMAGGE B, Labuschagne L, Pijpers J, van Roon A, et al
   Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands.
   Epidemiol Infect. 2025;153:e87.
   PubMed     Abstract available
   
   
   
10. COLEMAN BL, Robertson NM, Harrison RA, Valiquette L, et al
    Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.
    Epidemiol Infect. 2025;153:e72.
    PubMed     Abstract available
    
    
    
11. ABEYKOON AMH, Wilson M, Subbarao K, Geard N, et al
    Severe acute respiratory syndrome coronavirus-2 shedding in exhaled material: a systematic review.
    Epidemiol Infect. 2025;153:e75.
    PubMed     Abstract available
    
    
    
12. BARBER CA, Chien LC, Labus B, Crank K, et al
    Application of joinpoint regression to SARS-CoV-2 wastewater-based epidemiology in Las Vegas, Nevada, USA.
    Epidemiol Infect. 2025;153:e68.
    PubMed     Abstract available
    
    
    March 2025
13. ABUCAR EAM, Kern M, Kurth T, Meierkord A, et al
    Health-related quality of life up to 2 years after SARS-CoV-2 infection: a descriptive cohort study.
    Epidemiol Infect. 2025;153:e60.
    PubMed     Abstract available
    
    
    
14. STERIAN M, Naganathan T, Corrin T, Waddell L, et al
    Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: an updated living systematic review.
    Epidemiol Infect. 2025;153:e62.
    PubMed     Abstract available
    
    
    
15. CHEN C, Chen D, Du Y, Jiang D, et al
    Global patterns and trends in deaths of influenza-associated lower respiratory infections from 1990 to 2019.
    Epidemiol Infect. 2025;153:e49.
    PubMed     Abstract available
    
    
    
16. SUOMENRINNE-NORDVIK A, Leino T, Shubin M, Auranen K, et al
    Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era.
    Epidemiol Infect. 2025;153:e59.
    PubMed     Abstract available
    
    
    
17. MIN KH, Kim JH, Gil JY, Park JH, et al
    Factors associated with carditis adverse events following SARS-COV-2-19 vaccination.
    Epidemiol Infect. 2025;153:e51.
    PubMed     Abstract available
    
    
    
18. MONGE S, Humphreys J, Nicolay N, Braeye T, et al
    Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.
    Epidemiol Infect. 2025;153:e54.
    PubMed     Abstract available
    
    
    
19. WITTEVEEN-FREIDL G, Lauenborg Moller K, Voldstedlund M, Gubbels S, et al
    Data for action - description of the automated COVID-19 surveillance system in Denmark and lessons learnt, January 2020 to June 2024.
    Epidemiol Infect. 2025;153:e58.
    PubMed     Abstract available
    
    
    
20. WASIK BR, Damodaran L, Maltepes MA, Voorhees IEH, et al
    THE EVOLUTION AND EPIDEMIOLOGY OF H3N2 CANINE INFLUENZA VIRUS AFTER 20 YEARS IN DOGS.
    Epidemiol Infect. 2025 Mar 5:1-38. doi: 10.1017/S0950268825000251.
    PubMed    
    
    
    February 2025
21. 
    Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?
    Epidemiol Infect. 2025;153:e44.
    PubMed     Abstract available
    
    
    
22. LIN W, Kung KH, Chan CL, Chuang SK, et al
    Characteristics and risk factors associated with COVID-19 reinfection in Hong Kong: a retrospective cohort study.
    Epidemiol Infect. 2025;153:e30.
    PubMed     Abstract available
    
    
    
23. HOEVE CE, Neppelenbroek N, Vos ERA, Huiberts AJ, et al
    Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
    Epidemiol Infect. 2025;153:e38.
    PubMed     Abstract available
    
    
    
24. SIMMS I, Charlett A, Colon-Gonzalez FJ, Blomquist PB, et al
    Adapting the Flexible Farrington Algorithm for daily situational awareness and alert system to support public health decision-making during the SARS-CoV-2 epidemic in England.
    Epidemiol Infect. 2025;153:e28.
    PubMed     Abstract available
    
    
    
25. PASCULLI P, Antonacci M, Zingaropoli MA, Dominelli F, et al
    SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypes.
    Epidemiol Infect. 2025;153:e40.
    PubMed     Abstract available
    
    
    January 2025
26. HAYES J, Lee SS, Carnevale J, Shamir D, et al
    Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.
    Epidemiol Infect. 2025;153:e27.
    PubMed     Abstract available
    
    
    
27. CAMPMAN SL, Boyd A, Schinkel J, Coyer L, et al
    SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.
    Epidemiol Infect. 2025;153:e23.
    PubMed     Abstract available
    
    
    
28. BEDNARSKA NG, Smith S, Bardsley M, Loveridge P, et al
    Trends in general practitioner consultations for hand foot and mouth disease in England between 2017 and 2022.
    Epidemiol Infect. 2025;153:e22.
    PubMed     Abstract available
    
    
    
29. CHANDA MM, Shivachandra SB, Mishra A, Punnoose P, et al
    Unique duck rearing practice in irrigated rice paddy fields driving recurrent H5N1 Avian Influenza outbreaks in two districts of Kerala, India.
    Epidemiol Infect. 2025 Jan 7:1-36. doi: 10.1017/S0950268824001882.
    PubMed    
    
    
    
30. BROWN J, Mook P, Vanhaverbeke M, Gimma A, et al
    Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe.
    Epidemiol Infect. 2025;153:e16.
    PubMed     Abstract available
    
    
    December 2024
31. NOSTAEVA A, Shimansky V, Apalko S, Kuznetsov I, et al
    Case-control association study between polygenic risk score and COVID-19 severity in a Russian population using low-pass genome sequencing.
    Epidemiol Infect. 2024;153:e13.
    PubMed     Abstract available
    
    
    
32. TYRRELL GJ, Croxen M, McCullough E, Li V, et al
    Group A streptococcal infections in Alberta, Canada 2018-2023.
    Epidemiol Infect. 2024;153:e35.
    PubMed     Abstract available
    
    
    
33. ARASHIRO T, Solante R, Sayo AR, Garcia RM, et al
    Factors associated with COVID-19 in-hospital death and COVID-19 vaccine effectiveness against COVID-19 hospitalization in the Philippines during pre-omicron and omicron period: A case-control study (MOTIVATE-P study).
    Epidemiol Infect. 2024;153:e18.
    PubMed     Abstract available
    
    
    
34. HUIBERTS AJ, Oosting IJ, de Melker HE, van de Wijgert JHHM, et al
    The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes.
    Epidemiol Infect. 2024;153:e5.
    PubMed     Abstract available
    
    
    
35. ZHENG C, Yu FY, Chan PS, Sun F, et al
    Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study.
    Epidemiol Infect. 2024;152:e166.
    PubMed     Abstract available
    
    
    
36. WANG S, Yan J, Song M, Xue Z, et al
    Development of a nomogram for high antibody titre of COVID-19 convalescent plasma.
    Epidemiol Infect. 2024;152:e167.
    PubMed     Abstract available
    
    
    
37. SANOGO IN, Fusade-Boyer M, Molia S, Koita OA, et al
    Identification of risk areas for avian influenza outbreaks in domestic poultry in Mali using the GIS-MCDA approach.
    Epidemiol Infect. 2024;152:e152.
    PubMed     Abstract available
    
    
    November 2024
38. WANG W, Li Q, Wang J
    A self-driven ESN-DSS approach for effective COVID-19 time series prediction and modelling.
    Epidemiol Infect. 2024;152:e146.
    PubMed     Abstract available
    
    
    
39. MARKELZ A, Zirnhelt Z, Morris K, Seys SA, et al
    Association between age of paediatric index cases and household SARS-CoV-2 transmission.
    Epidemiol Infect. 2024;152:e145.
    PubMed     Abstract available
    
    
    
40. SUTER J, Devos I, Matthes KL, Staub K, et al
    The health and demographic impacts of the "Russian flu" pandemic in Switzerland in 1889/1890 and in the years thereafter.
    Epidemiol Infect. 2024;152:e174.
    PubMed     Abstract available
    
    
    
41. ZHU W, Tang X, Chen Y, Chen M, et al
    Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.
    Epidemiol Infect. 2024;152:e144.
    PubMed     Abstract available
    
    
    
42. FERRONI E, Mateo-Urdiales A, Bietta C, Cesaroni G, et al
    Sex differences in response to COVID-19 mRNA vaccines in Italian population.
    Epidemiol Infect. 2024;152:e139.
    PubMed     Abstract available
    
    
    
43. GANDINI S, Conly J, Spencer EA, Evans D, et al
    Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential oro-faecal sources and evidence for transmission to humans.
    Epidemiol Infect. 2024;152:e138.
    PubMed     Abstract available
    
    
    
44. MAO S, Gu D, Wang D, Li P, et al
    Prevalence and prognosis of tinnitus in post-COVID-19 patients: a cross-sectional survey.
    Epidemiol Infect. 2024;152:e137.
    PubMed     Abstract available
    
    
    October 2024
45. YUN C, Lee Y, Heo SJ, Kim N, et al
    The impact of COVID-19 status and vaccine type following the first dose on acute heart disease: A nationwide retrospective cohort study in South Korea.
    Epidemiol Infect. 2024;152:e134.
    PubMed     Abstract available
    
    
    
46. BEDIR DEMIRDAG T, Ozcicek M, Polat M, Kavas FC, et al
    Effects of COVID-19 pandemic on epidemiological features of viral respiratory tract infections in children: a single-centre study.
    Epidemiol Infect. 2024;152:e128.
    PubMed     Abstract available
    
    
    
47. PIJNACKER R, Mughini-Gras L, Verhoef L, van den Beld M, et al
    Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands.
    Epidemiol Infect. 2024;152:e130.
    PubMed     Abstract available
    
    
    
48. ZHAO J, Huang X, Li X, Li B, et al
    The spatial-temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022.
    Epidemiol Infect. 2024;152:e124.
    PubMed     Abstract available
    
    
    
49. MCKEE CD, Yu EX, Garcia A, Jackson J, et al
    Superspreading of SARS-CoV-2: a systematic review and meta-analysis of event attack rates and individual transmission patterns.
    Epidemiol Infect. 2024;152:e121.
    PubMed     Abstract available
    
    
    
50. WANG H, Varol T, Gultzow T, Zimmermann HML, et al
    Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: a Bayesian ecological modelling analysis.
    Epidemiol Infect. 2024;152:e119.
    PubMed     Abstract available
    
    
    
51. SHAW STEWART PD
    Will COVID-19 become mild, like a cold?
    Epidemiol Infect. 2024;152:e120.
    PubMed     Abstract available
    
    
    
52. PENDREY CGA, Khvorov A, Nghiem S, Rahaman MR, et al
    Hospitalizations and emergency attendance averted by influenza vaccination in Victoria, Australia, 2017 - 2019.
    Epidemiol Infect. 2024;152:e111.
    PubMed     Abstract available
    
    
    
53. CHARLES H, Sinka K, Simms I, Baker KS, et al
    Trends in shigellosis notifications in England, January 2016 to March 2023.
    Epidemiol Infect. 2024;152:e115.
    PubMed     Abstract available
    
    
    
54. MOORE HL, Turner C, Rawlinson C, Chen C, et al
    Risk factors for COVID-19 transmission in England: a multilevel modelling study using routine contact tracing data.
    Epidemiol Infect. 2024;152:e112.
    PubMed     Abstract available
    
    
    September 2024
55. ANDREYCHYN M, Melnyk L, Zavidniiuk N, Nychyk N, et al
    Interleukins in the pathogenesis of influenza and other acute respiratory viral infections.
    Epidemiol Infect. 2024;152:e109.
    PubMed     Abstract available
    
    
    
56. MELTZER HC, Goodwin JL, Fowler LA, Britt TW, et al
    Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody detection in South Carolina emergency healthcare workers, September 2019-March 2020.
    Epidemiol Infect. 2024;152:e102.
    PubMed     Abstract available
    
    
    
57. CHARLAND K, Pierce L, Saucier A, Hamelin ME, et al
    Omicron incidence and seroprevalence among children in Montreal, Canada, in early 2023: final results from the longitudinal EnCORE serology study.
    Epidemiol Infect. 2024;152:e103.
    PubMed     Abstract available
    
    
    August 2024
58. RIOU J, Studer E, Fesser A, Schuster TM, et al
    Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine data.
    Epidemiol Infect. 2024;152:e100.
    PubMed     Abstract available
    
    
    June 2024
59. ALSHAMRANI MM, El-Saed A, Aldayhani O, Alhassan A, et al
    Risk of central line-associated bloodstream infections during COVID-19 pandemic in intensive care patients in a tertiary care centre in Saudi Arabia.
    Epidemiol Infect. 2024;152:e95.
    PubMed     Abstract available
    
    
    May 2024
60. LOVE NK, Jenkins C, McCarthy N, Baker KS, et al
    International travel as a risk factor for gastrointestinal infections in residents of North East England.
    Epidemiol Infect. 2024;152:e97.
    PubMed     Abstract available
    
    
    
61. LASANDER M, Elo K, Joronen K, Dub T, et al
    Barriers to vaccine acceptance in the adult population of mainland Finland, 2021 - ERRATUM.
    Epidemiol Infect. 2024;152:e79.
    PubMed    
    
    
    
62. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    PubMed     Abstract available
    
    
    
63. BERIKOPOULOU MM, Dessypris N, Kalogera E, Petridou E, et al
    Epidemiology of respiratory syncytial virus in hospitalized children before, during, and after the COVID-19 lockdown restriction measures in Greece.
    Epidemiol Infect. 2024;152:e94.
    PubMed     Abstract available
    
    
    
64. BEALE S, Yavlinsky A, Fong WLE, Nguyen VG, et al
    Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.
    Epidemiol Infect. 2024;152:e77.
    PubMed     Abstract available
    
    
    April 2024
65. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    PubMed     Abstract available
    
    
    
66. CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
    Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
    Epidemiol Infect. 2024;152:e66.
    PubMed     Abstract available
    
    
    
67. TSANG TK, Du RQR, Fang VJ, Lau EHY, et al
    Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.
    Epidemiol Infect. 2024 Apr 8:1-21. doi: 10.1017/S0950268824000542.
    PubMed    
    
    
    
68. GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
    Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
    Epidemiol Infect. 2024;152:e69.
    PubMed     Abstract available
    
    
    March 2024
69. NESTERUK I
    Should we ignore SARS-CoV-2 disease?
    Epidemiol Infect. 2024;152:e57.
    PubMed     Abstract available
    
    
    
70. PENG L, Huang X, Wang C, Xin H, et al
    Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
    Epidemiol Infect. 2024;152:e43.
    PubMed     Abstract available
    
    
    
71. MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al
    Rapid assessment of data systems for COVID-19 vaccination in the WHO African Region.
    Epidemiol Infect. 2024;152:e50.
    PubMed     Abstract available
    
    
    
72. LOZANO D, Dohoo C, Elfstrom D, Carswell K, et al
    COVID-19 outbreak at a residential apartment building in Northern Ontario, Canada.
    Epidemiol Infect. 2024;152:e53.
    PubMed     Abstract available
    
    
    February 2024
73. YAP WK, Attwell K
    Medical exemptions to mandatory vaccinations: The state of play in Australia and a pressure point to watch.
    Epidemiol Infect. 2024;152:e40.
    PubMed     Abstract available
    
    
    
74. HOEG TB, Haslam A, Prasad V
    The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds.
    Epidemiol Infect. 2024;152:e51.
    PubMed     Abstract available
    
    
    
75. WAITE LL, Nahhas A, Irvahn J, Garden G, et al
    COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Epidemiol Infect. 2024;152:e36.
    PubMed     Abstract available
    
    
    
76. GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al
    Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.
    Epidemiol Infect. 2024;152:e30.
    PubMed     Abstract available
    
    
    January 2024
77. YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al
    Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
    Epidemiol Infect. 2024;152:e24.
    PubMed     Abstract available
    
    
    
78. BIRD O, Galiza EP, Baxter DN, Boffito M, et al
    The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Epidemiol Infect. 2024;152:e37.
    PubMed     Abstract available
    
    
    
79. ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al
    Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
    Epidemiol Infect. 2024;152:e16.
    PubMed     Abstract available
    
    
    
80. SARKER P, Haq MA, Akhtar E, Roy AK, et al
    Serosurveillance among urban slum and non-slum populations immunized with COVID-19 vaccines in Bangladesh.
    Epidemiol Infect. 2024;152:e14.
    PubMed     Abstract available
    
    
    
81. LIEPINS T, Davie G, Miller R, Whitehead J, et al
    Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand: Examining the national roll-out.
    Epidemiol Infect. 2024;152:e7.
    PubMed     Abstract available
    
    
    December 2023
82. SCHWARTZ RA, Suskind RM
    Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
    Epidemiol Infect. 2023;152:e34.
    PubMed     Abstract available
    
    
    
83. PARRON I, Carol M, Bes N, Izquierdo C, et al
    The impact of COVID-19 pandemic on the incidence of acute gastroenteritis outbreaks in Catalonia (Spain).
    Epidemiol Infect. 2023;152:e10.
    PubMed     Abstract available
    
    
    November 2023
84. ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al
    Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population - a case-control study.
    Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863.
    PubMed    
    
    
    
85. CHAVES-BLANCO L, de Salazar A, Fuentes A, Vinuela L, et al
    Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time allele-specific PCR strategy: an advantage for clinical practice.
    Epidemiol Infect. 2023;151:e201.
    PubMed     Abstract available
    
    
    
86. GULLE BT, Oren MM, Dal T
    COVID-19 vaccine hesitancy in Turkey: A systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e199.
    PubMed     Abstract available
    
    
    
87. ELGERSMA IH, Fretheim A, Elstrom P, Aavitsland P, et al
    Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study.
    Epidemiol Infect. 2023;151:e194.
    PubMed     Abstract available
    
    
    
88. JIANG H, Gu Z, Liu H, Huang J, et al
    Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR model.
    Epidemiol Infect. 2023;152:e9.
    PubMed     Abstract available
    
    
    
89. MERINO P, Kupferwasser D, Flores EA, Phan Tran D, et al
    Skin and soft tissue infection incidence before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023;151:e190.
    PubMed     Abstract available
    
    
    October 2023
90. SEGHEZZO G, Nash SG, Aziz NA, Hope R, et al
    Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.
    Epidemiol Infect. 2023;151:e189.
    PubMed     Abstract available
    
    
    
91. DAVID JA, Kolipakkam B, Morales MK, Vissichelli NC, et al
    Cell-free plasma next-generation sequencing assists in the evaluation of secondary pneumonia in patients with COVID-19: a case series.
    Epidemiol Infect. 2023;151:e185.
    PubMed     Abstract available
    
    
    
92. RODRIGUEZ-DEL-RIO FJ, Barroso P, Fernandez-de-Mera IG, de la Fuente J, et al
    COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.
    Epidemiol Infect. 2023;151:e188.
    PubMed     Abstract available
    
    
    
93. FLANNAGAN J, Chudasama DY, Hope R, Collin SM, et al
    Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.
    Epidemiol Infect. 2023;151:e191.
    PubMed     Abstract available
    
    
    
94. KIM JY, Lee WJ, Suh JW, Kim SB, et al
    Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Epidemiol Infect. 2023;151:e180.
    PubMed     Abstract available
    
    
    
95. WONG R, Lovier MA
    Racial and ethnic disparities in COVID-19 diagnosis and adherence to mitigation behaviours in a national United States older adult sample.
    Epidemiol Infect. 2023;151:e175.
    PubMed     Abstract available
    
    
    
96. CANELAS-FERNANDEZ J, Mazagatos C, Delgado-Sanz C, Larrauri A, et al
    Influenza hospitalizations in Spain between the last influenza and COVID-19 pandemics. 2009-2019.
    Epidemiol Infect. 2023 Oct 4:1-32. doi: 10.1017/S0950268823001620.
    PubMed    
    
    
    
97. ZHENG L, Qiu L, Wu L, Wang J, et al
    Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and clinical outcomes in hospitalised COVID-19 patients.
    Epidemiol Infect. 2023;151:e173.
    PubMed     Abstract available
    
    
    September 2023
98. GOPAL RAO G, Jinjika S, James D, Mukombe N, et al
    Nosocomial outbreak in a respiratory ward caused by the SARS-CoV-2 Omicron BA 5.2.1 subvariant associated with non-severe illness in vaccinated patients.
    Epidemiol Infect. 2023;151:e171.
    PubMed     Abstract available
    
    
    
99. TWOHIG KA, Harman K, Zaidi A, Aliabadi S, et al
    Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
    Epidemiol Infect. 2023;151:e169.
    PubMed     Abstract available
    
    
    
100. MITANGALA PN, Irenge LM, Musubao ET, Kahindo JBM, et al
     Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
     Epidemiol Infect. 2023;151:e167.
     PubMed     Abstract available
     
     
     
101. ZHAO T, Yang Z, Wu Y, Yang J, et al
     Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis.
     Epidemiol Infect. 2023;151:e176.
     PubMed     Abstract available
     
     
     
102. NDZIESSI G, Niama RF, Aloumba AG, Peya JM, et al
     Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.
     Epidemiol Infect. 2023;151:e162.
     PubMed     Abstract available
     
     
     
103. MELLOR J, Overton CE, Fyles M, Chawner L, et al
     Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.
     Epidemiol Infect. 2023;151:e172.
     PubMed     Abstract available
     
     
     August 2023
104. GUHA SK, Sadhukhan S, Niyogi S
     COVID-19 cluster identification and support vector machine classifier model construction using global healthcare and socio-economic features.
     Epidemiol Infect. 2023;151:e159.
     PubMed     Abstract available
     
     
     
105. GOLDSTEIN E
     Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
     Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.
     PubMed    
     
     
     
106. SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
     Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
     Epidemiol Infect. 2023;151:e146.
     PubMed     Abstract available
     
     
     
107. LOVE NK, Douglas A, Gharbia S, Hughes H, et al
     Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
     Epidemiol Infect. 2023;151:e147.
     PubMed     Abstract available
     
     
     
108. JENNINGS S, Corrin T, Waddell L
     A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
     Epidemiol Infect. 2023;151:e145.
     PubMed     Abstract available
     
     
     
109. SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al
     Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
     Epidemiol Infect. 2023;151:e140.
     PubMed     Abstract available
     
     
     
110. VERONESE G, Mahamid F, Bdier D
     Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
     Epidemiol Infect. 2023;151:e139.
     PubMed     Abstract available
     
     
     July 2023
111. WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al
     COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.
     Epidemiol Infect. 2023;151:e142.
     PubMed     Abstract available
     
     
     
112. HALEVI A, Shkalim Zemer V, Embar T, Jacobson E, et al
     Attitudes toward COVID-19 vaccination of healthcare workers in Israel and vaccination rates during vaccine rollout.
     Epidemiol Infect. 2023;151:e132.
     PubMed     Abstract available
     
     
     
113. DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al
     Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.
     Epidemiol Infect. 2023;151:e126.
     PubMed     Abstract available
     
     
     
114. FUNK T, Espenhain L, Moller FT, Ethelberg S, et al
     Factors associated with the formation of SARS-CoV-2 case-clusters in Danish schools: a nationwide register-based observational study.
     Epidemiol Infect. 2023;151:e168.
     PubMed     Abstract available
     
     
     
115. GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al
     Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis.
     Epidemiol Infect. 2023;151:e123.
     PubMed     Abstract available
     
     
     
116. BLACKBURN AM, Han H, Gallegos A
     Cross-language validation of COVID-19 Compliance Scale in 28 languages.
     Epidemiol Infect. 2023;151:e119.
     PubMed     Abstract available
     
     
     
117. ROGERS JH, Cox SN, Link AC, Nwanne G, et al
     Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
     Epidemiol Infect. 2023;151:e129.
     PubMed     Abstract available
     
     
     
118. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
     Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM.
     Epidemiol Infect. 2023;151:e108.
     PubMed    
     
     
     
119. KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al
     Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
     Epidemiol Infect. 2023;151:e116.
     PubMed     Abstract available
     
     
     
120. RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al
     Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.
     Epidemiol Infect. 2023;151:e113.
     PubMed     Abstract available
     
     
     
121. TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al
     Shift from a Zero-COVID strategy to a New-normal strategy for controlling SARS-COV-2 infections in Vietnam.
     Epidemiol Infect. 2023;151:e117.
     PubMed     Abstract available
     
     
     June 2023
122. GUO Y, Zeng X, Li L, Wang L, et al
     The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
     Epidemiol Infect. 2023;151:e135.
     PubMed     Abstract available
     
     
     
123. LUO Y, Li Y, Xiao S, Lei H, et al
     Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.
     Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012.
     PubMed    
     
     
     
124. RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al
     Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 - Corrigendum.
     Epidemiol Infect. 2023;151:e91.
     PubMed    
     
     
     
125. LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al
     One health surveillance strategy for coronaviruses in Italian wildlife.
     Epidemiol Infect. 2023;151:e96.
     PubMed     Abstract available
     
     
     
126. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
     Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.
     Epidemiol Infect. 2023;151:e98.
     PubMed     Abstract available
     
     
     May 2023
127. HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al
     Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
     Epidemiol Infect. 2023;151:e99.
     PubMed     Abstract available
     
     
     
128. SABIR QUA, Shafqat A, Aslam M
     Prediction of the COVID-19 transmission: a case study of Pakistan.
     Epidemiol Infect. 2023;151:e89.
     PubMed     Abstract available
     
     
     
129. LUO E, Zhong Q, Wen Y, Cai J, et al
     Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.
     Epidemiol Infect. 2023;151:e128.
     PubMed     Abstract available
     
     
     
130. CHANG H, Zhang X, Su H, Cai J, et al
     Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
     Epidemiol Infect. 2023;151:e81.
     PubMed     Abstract available
     
     
     
131. SCHOEPS A, Walter J, Vogt M, Bent S, et al
     Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021.
     Epidemiol Infect. 2023;151:e80.
     PubMed     Abstract available
     
     
     
132. SHI T, Huang L
     Prevalence of respiratory pathogens and risk of developing pneumonia under non-pharmaceutical interventions in Suzhou, China.
     Epidemiol Infect. 2023;151:e82.
     PubMed     Abstract available
     
     
     April 2023
133. JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al
     Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.
     Epidemiol Infect. 2023;151:e83.
     PubMed     Abstract available
     
     
     
134. FRILLI E, Amodeo D, Cevenini G, Nante N, et al
     Effectiveness of near-UVA in SARS-CoV-2 inactivation.
     Epidemiol Infect. 2023;151:e76.
     PubMed     Abstract available
     
     
     
135. MERCKX J, Callies M, Kabouche I, Desombere I, et al
     SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
     Epidemiol Infect. 2023;151:e75.
     PubMed     Abstract available
     
     
     
136. WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al
     Inequities in COVID-19 Omicron infections and hospitalisations for Maori and Pacific people in Te Manawa Taki Midland region, New Zealand.
     Epidemiol Infect. 2023;151:e74.
     PubMed     Abstract available
     
     
     
137. ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al
     Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.
     Epidemiol Infect. 2023;151:e67.
     PubMed     Abstract available
     
     
     
138. PRABHU VG, Hand WR, Isik T, Song Y, et al
     Risk-adjusted policies to minimise perioperative staffing shortages during a pandemic: An agent-based simulation study.
     Epidemiol Infect. 2023;151:e66.
     PubMed     Abstract available
     
     
     
139. AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al
     Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
     Epidemiol Infect. 2023;151:e63.
     PubMed     Abstract available
     
     
     March 2023
140. GOODWIN B, Zia H, Lo DF
     Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a critical review.
     Epidemiol Infect. 2023;151:e52.
     PubMed    
     
     
     
141. ALLEN H, Tessier E, Turner C, Anderson C, et al
     Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
     Epidemiol Infect. 2023;151:e58.
     PubMed     Abstract available
     
     
     
142. MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al
     Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
     Epidemiol Infect. 2023;151:e48.
     PubMed     Abstract available
     
     
     February 2023
143. CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al
     Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19.
     Epidemiol Infect. 2023;151:e51.
     PubMed     Abstract available
     
     
     
144. SALAMA M, Amitai Z, Sheffer R
     Demographic and clinical characteristics of children and adolescents hospitalised with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
     Epidemiol Infect. 2023;151:e42.
     PubMed     Abstract available
     
     
     
145. ZHOU Y, Li Z, Wu W, Xiao J, et al
     Transmission trends of the global COVID-19 pandemic with combined effects of adaptive behaviours and vaccination.
     Epidemiol Infect. 2023;151:e39.
     PubMed     Abstract available
     
     
     
146. HU CY, Lei Y, Tang YW, Cui WS, et al
     Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
     Epidemiol Infect. 2023;151:e34.
     PubMed     Abstract available
     
     
     
147. MAIER BF, Rose AH, Burdinski A, Klamser P, et al
     Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany up to June 2022.
     Epidemiol Infect. 2023;151:e38.
     PubMed     Abstract available
     
     
     December 2022
148. WARD T, Glaser A, Overton CE, Carpenter B, et al
     Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
     Epidemiol Infect. 2022;151:e32.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.